Year archive

Everest Medicines Limited — 2025 filings

All 49 regulatory filings released by Everest Medicines Limited (1952) in 2025, sourced directly from the official regulator.

49 Filings

2025 Period

2025 filings (49)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD Director's Dealing	2025-12-31	English
VOLUNTARY ANNOUNCEMENT Legal Proceedings Report	2025-12-30	English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY DIRECTORS AND SUBSTANTIAL SHAREHOLDER OF THE COMPANY Director's Dealing	2025-12-15	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-12-11	English
(1) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE COMMERCIALIZATION SERVICE AGREEMENT; (2) CONNECTED TRANSACTION IN RELATION TO THE LICENSE AGREEMENT; AND (3) APPOINTMENT OF NON-EXECU Regulatory Filings	2025-12-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Share Issue/Capital Change	2025-11-06	English
VOLUNTARY ANNOUNCEMENT AGREEMENT WITH VISARA TO DEVELOP AND COMMERCIALIZE VIS-101 IN GREATER CHINA AND OTHER ASIAN MARKETS Regulatory Filings	2025-10-30	English
(1) GRANT OF OPTIONS (2) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED AWARD GRANT TO A CONNECTED PERSON Transaction in Own Shares	2025-10-10	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-10-10	English
CHANGES IN DIRECTORS, CHAIRMAN OF THE BOARD AND COMPOSITION OF THE NOMINATION COMMITTEE AND THE REMUNERATION COMMITTEE AND APPOINTMENT OF HONORARY CHAIRMAN Board/Management Information	2025-10-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Share Issue/Capital Change	2025-10-06	English
GRANT OF OPTIONS AND AWARDS Regulatory Filings	2025-10-02	English
Next Day Disclosure Return Share Issue/Capital Change	2025-09-05	English
2025 Interim Report Interim / Quarterly Report H1 2025	2025-09-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 Interim / Quarterly Report H1 2025	2025-08-29	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-06	English
VOLUNTARY ANNOUNCEMENT Capital/Financing Update	2025-08-01	English
Next Day Disclosure Return Share Issue/Capital Change	2025-08-01	English
COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-08-01	English
PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-07-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-07	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 27 JUNE 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-27	English
VOLUNTARY ANNOUNCEMENT Major Shareholding Notification	2025-06-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Share Issue/Capital Change	2025-06-05	English
Notification Letter to Registered Shareholders - Virtual Meeting Arrangements for the Annual General Meeting Proxy Solicitation & Information Statement	2025-06-03	English
The Pre-IPO Employee Equity Plan Regulatory Filings	2025-06-03	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 27 JUNE 2025 Proxy Solicitation & Information Statement	2025-06-03	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-06-03	English
(1) PROPOSED RE-ELECTION OF DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (3) PROPOSED RE-APPOINTMENT OF RETIRING AUDITOR; (4) NON-EXEMP Proxy Solicitation & Information Statement	2025-06-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-08	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE FULL APPROVAL OF NEFECON BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE TREATMENT OF PRIMARY IMMUNOGLOBULIN A NEPHROPATHY IN ADULTS AT RISK OF DISEAS Regulatory Filings	2025-05-07	English
REMOVAL OF STOCK MARKER "B" Regulatory Filings	2025-04-25	English
2024 Environmental, Social and Governance Report Environmental & Social Information	2025-04-24	English
2024 Annual Report Annual Report FY 2024	2025-04-24	English
DIS-APPLICATION OF RULES 18A.09 TO 18A.11 OF THE LISTING RULES Regulatory Filings	2025-04-22	English
(1) CHANGE OF COMPANY SECRETARY (2) CLARIFICATION REGARDING THE PRE-IPO ESOP Board/Management Information	2025-04-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Share Issue/Capital Change	2025-04-07	English
(1) GRANT OF OPTIONS (2) GRANT OF AWARDS (3) NON-EXEMPT CONNECTED TRANSACTIONS - PROPOSED AWARD GRANTS TO CONNECTED PERSONS Remuneration Information	2025-04-01	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024 Annual Report FY 2024	2025-03-25	English
Terms of Reference of the Nomination Committee Governance Information	2025-03-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Share Issue/Capital Change	2025-03-06	English
DATE OF BOARD MEETING Regulatory Filings	2025-02-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-06	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2025-01-10	English
UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS Major Shareholding Notification	2025-01-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-07	English